
Ryuji Koike
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 110 publications
Methotrexate and Malignancy in Rheumatoid Arthritis: Evidence, Risks, and Clinical Considerations.
Journal: Modern rheumatology
Published: May 27, 2026
Clinical features and prognostic factors of adult systemic chronic active EBV disease: A retrospective analysis in Japan.
Journal: British journal of haematology
Published: January 01, 2026
Multidisciplinary genomic evaluation reveals adult inborn errors of immunity with rheumatic features.
Journal: Journal of human immunity
Published: October 08, 2025
CT-based phenotyping of COVID-19: cluster analysis of pulmonary and extrapulmonary imaging markers from a multicentre retrospective cohort study.
Journal: Scientific reports
Published: August 29, 2025
Extent of pulmonary involvement on admission predicts long-term pulmonary and muscular sequelae of COVID-19: A longitudinal computed tomography study.
Journal: Respiratory investigation
Published: August 13, 2025
Unraveling the COVID-19 Severity Hubs and Interplays in Inflammatory-Related RNA-Protein Networks.
Journal: International journal of molecular sciences
Published: April 02, 2025
Integrated assessment of total airway count and pneumonia volume on chest computed tomography as a prognostic biomarker for coronavirus disease.
Journal: European radiology
Published: March 22, 2025
Coronary Artery Calcification on Chest Computed Tomography as a Predictor of Cardiovascular Adverse Events in Patients With COVID-19 - A Multicenter Retrospective Study in Japan.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: January 19, 2025
Consolidation-to-ground-glass opacity ratio on chest CT as a prognostic marker for critical outcomes in COVID-19: a retrospective cohort study.
Journal: BMC pulmonary medicine
Published: January 07, 2025
Corrigendum to 'Impact of accumulative smoking exposure and chronic obstructive pulmonary disease on COVID-19 outcomes: report based on findings from the Japan COVID-19 task force' [IJID 128 (2023) 121-127].
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: December 11, 2024
Iguratimod, a promising therapeutic agent for COVID-19 that attenuates excessive inflammation in mouse models.
Journal: European journal of pharmacology
Published: November 27, 2024
Last Updated: 09/26/2026